✦ LIBER ✦

733 Interim (week 12) phase 2b virological efficacy and safety results of albumin interferon Alpha-2b combined with ribavirin in genotype 1 chronic hepatitis C infection

✍ Scribed by S. Zeuzem; Y. Benhamou; D. Shouval; V. Bain; S. Pianko; R. Flisiak; M. Grigorescu; V. Rehak; E. Yoshida; K. Kaita; C. Hezode; A.U. Neumann; M. Subramanian; J. McHutchison

Book ID: 117375008
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 114 KB
Volume: 44
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(06)80733-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

O.127 Phase 2b interim (week 12) results

O.127 Phase 2b interim (week 12) results of albumin interferon alpha-2b combined with ribavirin in IFN-naïve, genotype 1 chronic hepatitis C infection

✍ Y. Benhamou; S. Zeuzem; D. Shouval; V. Bain; S. Pianko; R. Flisiak; M. Grigoresc 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 276 KB

272 EARLY VIRAL RESPONSE OF CONTROLLED-R

272 EARLY VIRAL RESPONSE OF CONTROLLED-RELEASE INTERFERON ALPHA2B AND RIBAVIRIN VS. PEGYLATED-INTERFERON ALPHA2B AND RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE1 HEPATITIS C: 12 WEEK RESULTS (SELECT-2 TRIAL)

✍ E. Lawitz; Z. Younossi; P. Mehra; A. Rigney; Z. Krastev; K. Tchernev; D. Takov; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Mutations in the interferon sensitivity

Mutations in the interferon sensitivity determining region and virological response to combination therapy with pegylated-interferon alpha 2b plus ribavirin in patients with chronic hepatitis C-1b infection

✍ Mina Nakagawa; Naoya Sakamoto; Mayumi Ueyama; Kaoru Mogushi; Satoshi Nagaie; Yas 📂 Article 📅 2010 🏛 Springer Japan 🌐 English ⚖ 266 KB

1042 EFFICACY AND SAFETY RESULTS OF ALBI

1042 EFFICACY AND SAFETY RESULTS OF ALBINTERFERON ALFA-2B IN COMBINATION WITH RIBAVIRIN IN INTERFERON-ALFA TREATMENT NAIVE PATIENTS WITH GENOTYPE 2 OR 3 CHRONIC HEPATITIS C

✍ Nelson, D.; Benhamou, Y.; Chuang, W.L.; Lawitz, E.; Flisiak, R.; Rodriguez-Torre 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

P.264 Viusid in combination with interfe

P.264 Viusid in combination with interferon alpha-2b and ribavirin in patients with chronic hepatitis C. Efficacy and safety results from a ramdomized controlled trial

✍ E. Vilar Gómez; B. Grá; E. Arús Soler; C. Ruenes Domech; Y. Betancourt 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 141 KB

Effects of the combination of PEG-interf

Effects of the combination of PEG-interferon alpha-2B and ribavirin on the inflammation and fibrosis scores of patients with chronic hepatitis C infection who were virologic non-responders to interferon alpha-2B and ribavirin

✍ Tarek I. Hassanein; Fatma M. Barakat; Cynthia Behling; Wendy Y. Myers; Meghan D. 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 67 KB